Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.8K citations

Medicine, Oncology, Radiation Oncology +17

Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments

Brain Pathology · 2009 · 4K citations · Full text

Medicine, Immunology, Oncology +16

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

Mark E. Davis, Jonathan E. Zuckerman, Chung Hang Jonathan Choi et al. · Nature · 2010 · 2.5K citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmacology +12

Development and characterisation of chitosan nanoparticles for siRNA delivery

Haliza Katas, H. Oya Alpar · Journal of Controlled Release · 2006 · 642 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutical Biotechnology +14

Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection

Natalia Rubinstein, Mariano J. Alvarez, Norberto W. Zwirner et al. · Cancer Cell · 2004 · 524 citations · Full text

Medicine, Immunology, Oncology +15